A wegovy pen in shadow
  • Companies can't afford to pay for weight-loss shots for all their workers who qualify.
  • But Novo Nordisk, the maker of Wegovy, is penalizing employers for partially restricting access.
  • So two employers in Texas and North Carolina scrapped weight-loss drug coverage altogether.

There's a little-known reason more companies aren't paying for their workers' weight-loss shots.

Sure, the drugs cost a lot. For many employers, paying for the $1,000-a-month shots for the vast numbers of workers with obesity or overweight could put them out of business.